# Abbott Laboratories (ABT) — Q4-2021 Earnings Results

**Report date:** 2022-01-26 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2021

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Down 2.6%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.32 | N/A | +11.86% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No forward guidance data is available.

### What It Means

Abbott Laboratories reported a better-than-expected EPS, exceeding estimates by nearly 12%. However, the stock fell by 2.6% following the announcement, indicating that investors may have been looking for more comprehensive revenue details or guidance. The lack of additional information from management could have contributed to the stock's decline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2021_